Clinical Trials Logo

Clinical Trial Summary

Untreated maternal infection with gonorrhea and/or chlamydia can have serious complications in pregnancy and the neonatal period. In Ontario, routine screening for these infections is done in the first trimester of pregnancy, positive cases are treated with antibiotics, and all newborns are given antibiotic eye ointment within 24 hours of birth. Recently, the Canadian Pediatric Society recommended stopping universal prophylaxis for newborns, with instead, focus on screening and treatment of these infections in pregnancy. Given that these infections can occur at any time in pregnancy, and exposure at delivery provides a significant risk to infants, more information is needed about the rates of infection throughout pregnancy and health-care provider compliance with guidelines to make this change without undue risk. With this information optimal timing of testing can be evaluated.


Clinical Trial Description

The primary objective of this study is to retrospectively examine the incidence rates of N. gonorrhoeae (NG) and C. trachomatis (CT) in the first and third trimester for the obstetrical population at St. Michael's Hospital over the course of six months. Secondary objectives include (1) feasibility of instituting third trimester screening for sexually transmitted infections, and (2) assessment of physician compliance with Canadian screening and treatment guidelines. This information will help us to deduce the optimal timing of screening for NG and CT in the obstetrical population at St. Michael's Hospital.

It is hypothesized that the incidence rates of both NG and CT infections will be low, but that much can be learned from the positive cases in terms of risk factors and optimal timing of screening. Further, the feasibility of screening in the third trimester will offer options for future guidelines. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03073538
Study type Observational
Source St. Michael's Hospital, Toronto
Contact
Status Completed
Phase
Start date November 2016
Completion date February 2019

See also
  Status Clinical Trial Phase
Completed NCT00381992 - Risk Assessment of Long-Haul Truck Drivers N/A
Completed NCT00115388 - Community-Based Trial of Screening for Chlamydia Trachomatis to Prevent Pelvic Inflammatory Disease N/A
Completed NCT00005496 - Inflammation, Infection, and Future Cardiovascular Risk N/A
Completed NCT00207506 - Lay Health Advisors for Sexually Transmitted Disease Prevention Phase 1/Phase 2
Completed NCT00132457 - Use of Self-collected Vaginal Swabs as an Innovative Approach to Facilitate Testing for Repeat Chlamydia Infection N/A
Terminated NCT00120770 - Cellulose Sulfate (CS) Gel and HIV in Nigeria Phase 3
Completed NCT00001890 - Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections Phase 2
Not yet recruiting NCT05727033 - Extraordinarily Fun Training Project in Compulsory Secondary Education - Sexually Transmitted Infections N/A
Completed NCT00561028 - Chlamydia and Mycoplasma in Coronary Artery Disease N/A
Completed NCT00112255 - Partner Notification for Chlamydia in Primary Care Phase 3
Completed NCT00252096 - Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections N/A
Completed NCT00037388 - Pediatrics:Chlamydia, Sickle Cell Anemia and Stroke Risk - Ancillary to STOP II N/A
Terminated NCT01728103 - Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays N/A
Completed NCT00607659 - Immunopathogenesis of Chlamydia N/A
Completed NCT00000120 - Clinical Trial of Eye Prophylaxis in the Newborn Phase 3
Completed NCT01638637 - Prospective Collection of Female and Male Specimens for PANTHER® System Testing N/A
Completed NCT03374696 - Theater in School Sex Education - a Randomized Controlled Study N/A
Active, not recruiting NCT00124878 - Trial of Male Circumcision: HIV, Sexually Transmitted Disease (STD) and Behavioral Effects in Men, Women and the Community Phase 3
Completed NCT00005547 - Infection and Cardiovascular Disease N/A